论文部分内容阅读
目的 :了解北京地区抗高血压药物的使用状况及发展趋势。方法 :采用协和医院《医院处方分析》系统 ,对1999年第2季度北京22家医院门诊处方抗高血压药物进行统计和分析。结果 :22家医院使用抗高血压药物共36种 ,51个品牌 ;钙拮抗剂占31 18 % ,ACEI占17 12 % ;用药频度最高的为硝苯地平、吲达帕胺、美托洛尔 ;金额靠前的为氨氯地平、洛汀新、拜心同。结论 :开发国产的长效制剂及新的复方降压药 ,是适应新的抗高血压指南和中国国情的需要。
Objective: To understand the status and development trend of antihypertensive drugs in Beijing. Methods: The Hospital Prescription Analysis System of Xiehe Hospital was used to conduct statistics and analysis of outpatient prescription antihypertensive drugs in 22 hospitals in the second quarter of 1999. RESULTS: Twenty-six hospitals used 36 antihypertensive drugs and 51 brands; calcium antagonists accounted for 31 18%; ACEI accounted for 1712%; and the highest frequency of medication was nifedipine, indapamide, and metoprolol. Seoul; the amount of the former is amlodipine, LoTING new, thanks to the same heart. Conclusion: The development of domestically produced long-acting agents and new compound antihypertensive agents are needed to adapt to the new anti-hypertension guidelines and China’s national conditions.